Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion de Jong

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Nuclear Medicine and Biology|July 14, 2016
Breast cancer imaging using radiolabelled somatostatin analoguesSimone U Dalm, Marleen Melis, Jasper Emmering, et al.
Pharmaceutics|November 2, 2019
The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical ResearchEline A M Ruigrok, Wytske M van Weerden, Julie Nonnekens, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 27, 2007
Neuroendocrine tumors. Peptide receptor radionuclide therapyFlavio Forrer, Roelf Valkema, Dik J Kwekkeboom, et al.
Nuclear Medicine and Biology|July 9, 2021
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [<sup>177</sup>Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumoursLorain Geenen, Julie Nonnekens, Mark Konijnenberg, et al.
Plos One|November 16, 2012
Segmentation and visual analysis of whole-body mouse skeleton microSPECTArtem Khmelinskii, Harald C Groen, Martin Baiker, et al.
Nuclear Medicine and Biology|February 16, 2010
Tumor uptake of 68Ga-DOTA-Tyr3-octreotate: animal PET studies of tumor flow and acute somatostatin receptor modulation in the CA20948 rat modelFrançois-Xavier Hanin, Stanislas Pauwels, Anne Bol, et al.
Royal Society Open Science|March 13, 2023
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkersErika Murce, Erik de Blois, Sophie van den Berg, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumoursMartijn Van Essen, Eric P Krenning, Marion De Jong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2005
111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapyAstrid Capello, Eric Krenning, Bert Bernard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptidesLeo J Hofland, Astrid Capello, Eric P Krenning, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Nuclear Medicine and Biology|July 14, 2016
Breast cancer imaging using radiolabelled somatostatin analoguesSimone U Dalm, Marleen Melis, Jasper Emmering, et al.
Pharmaceutics|November 2, 2019
The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical ResearchEline A M Ruigrok, Wytske M van Weerden, Julie Nonnekens, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 27, 2007
Neuroendocrine tumors. Peptide receptor radionuclide therapyFlavio Forrer, Roelf Valkema, Dik J Kwekkeboom, et al.
Nuclear Medicine and Biology|July 9, 2021
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [<sup>177</sup>Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumoursLorain Geenen, Julie Nonnekens, Mark Konijnenberg, et al.
Plos One|November 16, 2012
Segmentation and visual analysis of whole-body mouse skeleton microSPECTArtem Khmelinskii, Harald C Groen, Martin Baiker, et al.
Nuclear Medicine and Biology|February 16, 2010
Tumor uptake of 68Ga-DOTA-Tyr3-octreotate: animal PET studies of tumor flow and acute somatostatin receptor modulation in the CA20948 rat modelFrançois-Xavier Hanin, Stanislas Pauwels, Anne Bol, et al.
Royal Society Open Science|March 13, 2023
Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkersErika Murce, Erik de Blois, Sophie van den Berg, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumoursMartijn Van Essen, Eric P Krenning, Marion De Jong, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2005
111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapyAstrid Capello, Eric Krenning, Bert Bernard, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptidesLeo J Hofland, Astrid Capello, Eric P Krenning, et al.
Pageof 20